Scienture Holdings (SCNX) Surges on Coverage Breakthrough – Can This Pharma Underdog Deliver?

Scienture Holdings, Inc. is a tiny specialty pharmaceutical company focused on developing and commercializing novel formulations that address unmet needs in healthcare Globenewswire Globenewswire. The company’s roots trace back to a 2024 merger with TRxADE Health, a drug marketplace business – after which the combined entity rebranded as Scienture Nasdaq. In early 2025, management decisively pivoted to pharma: selling off legacy pharmacy/IT subsidiaries for $5 million to free up resources and “dedicate full focus” to its specialty drug pipeline Globenewswire Globenewswire.